Parents infuriated over wait for swine flu vaccine Oct 26, 2009
Worse, it prevents the administration of the pandemic flu vaccine that's in most abundant supply locally, the FluMist H1N1 live-virus nasal spray, made by Medimmune, a subsidiary of AstraZeneca. Giving the live virus vaccines too close together can prevent an effective immune response, doctors say. (The Palm Beach Post)
D.C.-area biotechs set to pitch investors at Mid-Atlantic Bio Oct 24, 2009
The chiefs of two of the largest local biotech players are also speakers this year Tom Watkins, CEO of Human Genome Sciences Inc., and Tony Zook, president of MedImmune, a division of London-based AstraZeneca PLC.. Organizers said while registrations have risen this year compared to the past two years of the conference -- they counted more than 800 attendees at last year s event -- the recession has made its mark in a lower amount of sponsorships so far. (Washington Business Journal, DC)
Soccer Champ Promotes Flu Awareness Oct 24, 2009
Get Headlines Sent To Your Email Or Phone. Chastain Offers Tips To Players. (KCRA 3, CA)
Micromet, Inc. to Host Conference Call and Webcast to Report Third Quarter 2009 Financial Results on November 5, 2009 Oct 24, 2009
Micromet's collaboration partners include Bayer Schering Pharma, Merck Serono, MedImmune and Nycomed ... Factors that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include the risk that product candidates that appeared promising in early research, preclinical studies or clinical trials do not demonstrate safety and/or efficacy in subsequent clinical trials, the risk that encouraging results from early research,... (Primezone Releases)
Quest for swine flu vaccine giving some firms a boost Oct 22, 2009
All of the makers of swine flu vaccine for the US market are producing injectable doses, except MedImmune, which is producing a nasal spray ... MedImmune, based in Gaithersburg, Md ... This is really the first pandemic in 40 years, said Chris Ambrose, senior director of medical affairs for MedImmune. (Boston Globe)
Novavax, partner to test H1N1 vaccine Oct 21, 2009
Maria Allende, a former MedImmune vaccines executive who joined Novavax last year as its executive director of clinical research and immunology, will take Heaton s place and is currently in Mexico City supervising the start of the trials. After shooting up as much as 8 percent Tuesday morning, Novavax (NASDAQ: NVAX) shares by late afternoon were up 12 cents apiece, or a little more than 3 percent, to $3. (Washington Business Journal, DC)
H1N1 Kills 11 Kids in a Week Oct 18, 2009
It is also important to note that according to the manufacturer of the nasal spray, it will leave the vaccine recipient CONTAGIOUS for at least 3 weeks according to the maker of the product (MedImmune). See page 19 of their package insert after clicking on the link below. (CBS News)
MedImmune to present data on RSV and influenza at 2009 AAP National Conference and Exhibition Oct 17, 2009
WASHINGTON, October 16, 2009 MedImmune announced today it will present four abstracts at the American Academy of Pediatrics (AAP) 2009 National Conference ition that add to the company's growing body of research on the burden of respiratory syncytial virus (RSV) on children, as well as pediatric infectious disease prevention ... MedImmune abstracts to be presented at AAP on RSV include ... MedImmune abstracts to be presented at AAP on influenza include. (EurekAlert!)
Lawsuit Seeks to Halt U.S. Swine Flu Shots Oct 17, 2009
SIGN UP FOR FREE NEWS ALERTS. Friday, October 16, 2009 8:07 AM. (Newsmax)
Lawsuit seeks to halt H1N1 flu vaccination campaign in US Oct 16, 2009
Karen Lancaster, a spokeswoman for the MedImmune, which manufactures the nasal spray H1N1 vaccine, told AFP that the the company has had a seasonal flu vaccine made with weakened live virus on the market since 2003. This week, millions of doses stocks of injectable vaccine were delivered and administered to people in groups deemed to be at particular risk from H1N1 flu, including children and health care professionals. (Channelnewsasia.com)
UPDATE: County Has Received Small Amounts of H1N1 Flu Vaccines Oct 14, 2009
FluMist, made by MedImmune, also are offered for seasonal flu vaccines. Seasonal flu vaccines in spray and injection forms are already available. (Missourian Publishing, MO)
Poorer nations get swine flu jabs Oct 13, 2009
Sanofi-Adventis and GlaxoSmithKline are donating about 150 million doses of the vaccine, with an unspecified amount coming from a third company, Medimmune. The US is thought to be among nine or 10 rich countries which have also pledged to donate a proportion of their vaccines to developing nations - though the WHO says more doses are needed. (BBC News -- South Asia)
Poorer nations to get donated swine flu vaccine: WHO Oct 13, 2009
It will include about 150 million doses from two makers Sanofi-Aventis and GlaxoSmithKline (GSK), as well as an as yet unspecified amount from a third supplier, Medimmune, in the form of a nasal spray and the rich nation stocks, Kieny said. The donations to counter the threat from the flu pandemic that emerged in April would be directed to low and some middle income countries. (Yahoo! Asia News)
In Pakistan, Taliban force military to take action Oct 11, 2009
10:21 am October 10, 2009, by Jay. The most troubling development of the past year in Afghanistan/Pakistan was the widespread election fraud used to re-elect Hamid Karzai, which makes it difficult to sell his government as legitimate. (Atlanta Journal-Constitution -- Opinion)
Visa's New Goal Oct 10, 2009
Bank Failures Near 100 After hours: Irwin Financial falls; Astrazeneca's Medimmune to release first H1N1 vaccine. Week Ahead: RIMM, Fed New and existing home sales; KB Home, Lennar, General Mills report. (Forbes -- Business)
Md. suspends distribution of flu vaccine Oct 7, 2009
The seasonal FluMist is manufactured by MedImmune LLC, based in Gaithersburg. Most Read Stories. (Baltimore Business Journal, MD)
U.S. begins A/H1N1 flu vaccination with students, health workers Oct 6, 2009
The U.S. government has ordered about 250 million doses from five companies, namely Sanofi-Aventis SA, CSL Ltd., Novartis AG, GlaxoSmithKline and MedImmune. Some officials predicted that an ample supply of the injectable form will be available by mid-October. (Xinhuanet, China)
New Survey Suggests Americans Keen for H1N1 Vaccine Oct 6, 2009
The U.S. government has ordered about 250 million doses from five companies -- Sanofi-Aventis SA, CSL Ltd, AstraZeneca Plc's MedImmune unit, Novartis AG and GlaxoSmithKline. The vaccines will trickle in at a rate of about 20 million doses a week, and officials are unsure how many Americans will actually get them. (MEDLINEplus)
Dave Mott: Biotechs face tough road Oct 5, 2009
A year after selling Gaithersburg's MedImmune to London-based , Mott moved back last year to his investment banking roots to become a general partner at New Enterprise Associates, a Chevy Chase venture capital firm that focuses on health care, technology, energy and biotech companies. Three years from now, there will be one-third as many venture capital firms as there were three years ago, Mott said. (Baltimore Business Journal, MD)
U.S. Swine Flu Vaccines to Arrive from Tuesday Oct 3, 2009
Dr. Anne Schuchat of the U.S. Centers for Disease Control and Prevention said the first U.S. H1N1 vaccine to be delivered will be 600,000 doses of a nasal spray made by MedImmune, a division of AstraZeneca. "This is a bit earlier than we were planning to get started," Schuchat said in a telephone briefing. (MEDLINEplus)
Venture investing in Baltimore biotechs jumps Oct 3, 2009
The Lutherville company s investors include Philadelphia s Quaker BioVentures and MedImmune Ventures, a subsidiary of the AstraZeneca Group. Glen Burnie company Sleep Solutions Inc., which raised $20 million that it will use to develop treatments for sleeping disorders. (Baltimore Business Journal, MD)
Two-person Arginetix raises $11M in venture capital cash Oct 2, 2009
A year ago, they told Quaker and Gaithersburg-based MedImmune Ventures, the venture arm of AstraZeneca Group, that it would use its initial $2 ... The last time MedImmune Ventures invested in a Maryland company was in 2006, when it invested in Gaithersburg s Sequoia Pharmaceuticals Inc.. (Baltimore Business Journal, MD)
First shipment of H1N1 flu vaccine leaves factory Oct 1, 2009
Another vaccine maker, MedImmune, shipped its first batch of 5 million doses to regional distribution centers last Tuesday, company spokeswoman Karen Lancaster said. HHS bought 40 million doses from the company, she said. (CNN -- Health)
Majority of U.S. parents wary of H1N1 vaccine: poll Oct 1, 2009
The U.S. government has ordered vaccine from MedImmune, a unit of AstraZeneca, Sanofi-Aventis, Australia's CSL, GlaxoSmithKline and Novartis. U.S. health officials, who say immunization provides the best protection against flu infection, warn that low vaccine demand could now have dire consequences. (MSNBC -- Health)
U.S. Doubles Early Supply of Swine Flu Vaccine Sep 26, 2009
Most of the early doses will be MedImmune's nose spray ... The United States has ordered vaccine from five companies -- MedImmune, a unit of AstraZeneca, Sanofi-Aventis, Australia's CSL, GlaxoSmithKline and Novartis. (MEDLINEplus)
Flu is a booster for firms here Sep 26, 2009
MedImmune of Gaithersburg, Md ... Karen Lancaster, a MedImmune spokeswoman, said the company which this week received an order from HHS for an additional 29 million doses of its H1N1 influenza vaccine have enough sprayers to fill all existing government orders. (Philadelphia Business Journal, PA)
Age a factor in flu fight Sep 25, 2009
Overall, FluMist, manufactured by MedImmune Corp. of Gaithersburg, Md ... Karen Lancaster, a MedImmune spokeswoman, noted that "other studies have indicated that FluMist works just as well as -- or, in some cases, better -- than the flu shot. As a result, in adults, the jury is still out.". (Albany Times Union)
Nurses fight mandatory flu vaccinations Sep 24, 2009
If there are any adverse events it wont be the five drug companies Sanofi-Pasteur, CSL, GlaxoSmithKline, AstraZeneca's MedImmune unit, and Novartisin in the final stages of production of the H1N1 vaccine for the US market. The US Secretary of Health and Human Services, Kathleen Sebelius, signed a document in July granting immunity from prosecution to the five drug companies currently working on a H1N1 vaccine. (Hudson Register Star, NY)
Some stocks could gain from swine flu Sep 24, 2009
And Monday, the U.S. ordered more nasal-spray vaccine from AstraZeneca's (AZN) MedImmune. But there's reason to be skeptical. (AZCentral -- Business)
Study: Tots need booster for swine flu shot Sep 22, 2009
3 million coming from Sanofi Pasteur and 29 million from MedImmune, maker of FluMist, the companies announced. CDC is urging people to get seasonal vaccine now and not put off vaccination until swine flu vaccine is available. (Honolulu Advertiser)
One swine flu shot enough for older youths Sep 22, 2009
The extra orders were from Sanofi Pasteur s Pennsylvania flu-shot factory and from Maryland-based MedImmune LLC, which makes a nasal-spray version. In a separate development, Duke University researchers said they are developing a test to determine, with a mere drop of blood, who will get sick with the flu before the sniffling and fever set in. (Boston Globe)
Swine flu virus hasn't mutated, official says Sep 22, 2009
The vaccine is being made by CSL Ltd. of Australia, Switzerland's Novartis Vaccines, Maryland-based MedImmune LLC and Sanofi Pasteur of France which produces flu shots at its Swiftwater, Pennsylvania, factory. London-based GlaxoSmithKline also was expected to supply vaccine. (MSNBC -- Health)
Feds up vaccine order from MedImmune Sep 22, 2009
Government triples order for swine flu vaccines from MedImmune - Washington Business Journal ... Government triples order for swine flu vaccines from MedImmune ... MedImmune said the federal government has more than tripled its order of swine flu vaccines from the local biotech, bringing the government s total purchases up to $453 million since May. (Washington Business Journal, DC)
US Orders More H1N1 Flu Vaccine Sep 22, 2009
It also ordered 29 million more doses of the nasal-spray version of swine flu vaccine, MedImmune LLC's FluMist. The news came as health officials announced Monday that while people 10 and older are protected by one dose of swine flu vaccine, children 9 and younger almost certainly will need two. (Click2Houston, TX)
Schools, clinics brace for flu season Sep 20, 2009
Its manufacturer, MedImmune, is making an H1N1 FluMist that is expected to be available sometime in late October. Curran also prefers FluMist because it is more effective and has few if any side effects. (AZCentral -- News)
Swine Flu Vaccine Side Effects Sep 20, 2009
MedImmune LLC has received approval for a nasal spray H1N1 vaccine. While no safety data for this vaccine has been released to the public, MedImmune spokeswoman Karen Lancaster has that side effects are similar to those experienced with the nasal spray vaccine for the seasonal flu. (Suite101.com)
Q: Why is there a long delay in the broadcast of sporting events (including Georgia Tech’s season opener), meaning that the live action precedes the broadcast by 20 to 30 seconds? Sep 20, 2009
A: The FDA has approved CSL Ltd. of Australia, Maryland-based MedImmune LLC, Novartis Vaccines of Switzerland and Sanofi Pasteur of France (the flu shots are produced at its factory in Swiftwater, Pa. according to the Associated Press. (Atlanta Journal-Constitution -- World)
Approved Swine Flu Vaccines Sep 20, 2009
H1N1 Vaccine Made By MedImmune. The swine flu vaccine manufactured by MedImmune differs from the other three approved vaccines because it is distributed to recipients in the form of a nasal spray rather than an injection and is made with live, weakened swine flu virus. (Suite101.com)
3.4 million inhalable H1N1 vaccine doses near Sep 19, 2009
Sanofi Pasteur, Novartis and CSL Limited all manufacture flu shots, and MedImmune manufactures the inhalable vaccine. GlaxoSmithkline, which also is producing injectable flu vaccine, still needs to have its vaccine approved by the agency. (CNN)
1st swine-flu vaccine may come as nasal spray Sep 19, 2009
The nasal spray is only approved in the United States and is made by Maryland-based MedImmune, an AstraZeneca PLC subsidiary. Four other companies are making flu shots for the United States. (AZCentral -- News)
Rich countries to share some swine flu vaccine Sep 18, 2009
Fri, 08:02 18 Sep 2009 GMT. (Updates throughout with quotes, details). (AlertNet)
FDA Approves 4 Swine Flu Vaccines Sep 17, 2009
The four vaccines are made by CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and Sanofi Pasteur Inc. All four firms manufacture the H1N1 vaccines using the same processes, and have a proven safety record producing seasonal influenza vaccines, according to the FDA.. The preliminary trials of the vaccine have shown it to be well-tolerated, with side effects that are similar to those of seasonal flu vaccines. (MEDLINEplus)
New Swine Flu Vaccine Approved by FDA Sep 16, 2009
The vaccine approved Tuesday is made by CSL Ltd. of Australia; Switzerland's Novartis; Sanofi-Pasteur of France; and Maryland-based Medimmune, which makes the only nasal-spray flu vaccine. MORE.. (Time.com)
US drug regulator approves swine flu vaccine Sep 16, 2009
The vaccine treatments are produced by CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and Sanofi Pasteur Inc, and the FDA said all four firms use the same processes. The US government has purchased 195 million doses of swine flu vaccine and will make shots against the influenza A(H1N1) virus available free of charge starting next month, Sebelius said, although providers might charge a fee to administer them. (Yahoo! Asia News)
MedImmune wins OK for swine flu vaccine Sep 16, 2009
MedImmune wins federal OK for swine flu vaccine - Washington Business Journal ... MedImmune wins federal OK for swine flu vaccine ... A subsidiary of London-based (NYSE: AZN), MedImmune has been testing its swine flu vaccine candidate in two ongoing clinical trials, one for adults and one for children above the age of 2, each involving 300 patient volunteers. (Washington Business Journal, DC)
Clinical trial shows 1 H1N1 dose works Sep 11, 2009
Elsewhere, MedImmune of Gaithersburg, Md ... MedImmune researchers had found that the strain of virus it uses for its vaccine grows faster than that used by other manufacturers, speeding up the testing and manufacturing process. (AZCentral -- News)
Swine flu uptick seen as kids go back to school Sep 3, 2009
Five companies are making swine flu vaccine for the U.S. market AstraZeneca's MedImmune unit, CSL Ltd, GlaxoSmithKline Plc, Novartis AG and Sanofi-Aventis SA.. Seasonal flu infects between 5 percent and 20 percent of a given population every year but 90 percent of severe cases and deaths are among the elderly. (MSNBC -- Health)
No Flu Vaccines Before Mid-October, CDC Predicts Aug 28, 2009
Five companies are making swine flu vaccine for the U.S. market -- AstraZeneca's MedImmune unit, CSL Ltd, GlaxoSmithKline Plc, Novartis AG and Sanofi-Aventis SA. Tests have begun to determine if people will need one or two doses to be protected. WORST CASE PREDICTIONS. (MEDLINEplus)
Swine flu shots wont be ready before October Aug 27, 2009
Five companies are making swine flu vaccine for the U.S. market -- AstraZeneca's MedImmune unit, CSL Ltd, GlaxoSmithKline Plc, Novartis AG and Sanofi-Aventis SA. Tests have begun to determine if people will need one or two doses to be protected. Frieden also distanced himself from some of the worst-case predictions outlined in the council's report, which included a "plausible" estimate that between 30,000 and 90,000 people might die and up to 1. (MSNBC -- Health)
Schools on the Front Line of H1N1 Fight Aug 25, 2009
In the 2006-07 flu season, it was the first state to offer vaccinations in all public elementary schools, partly because of a large donation of nasal-spray vaccine by MedImmune, a biotech company in Gaithersburg. Several other states now offer or require statewide seasonal flu immunizations for children. (CBS News -- Health)
Speed up drugs; Needed in weeks... Aug 25, 2009
Reuters AlertNet - Speed up US flu drugs, vaccines-White House panel. Tue, 07:55 25 Aug 2009 GMT. (The Drudge Report)
Government Plans Vast Swine Flu Vaccine Effort... Aug 24, 2009
The federal government has spent close to $2 billion to buy up to 195 million doses of vaccine and adjuvant, including the standard shots and the newer FluMist nasal spray vaccine made by MedImmune of Gaithersburg. The government is prepared to buy enough to vaccinate every person -- 600 million doses all together -- if the pandemic or demand warrants it. (The Drudge Report)
No red flags in swine flushot tests Aug 22, 2009
Five companies are making both seasonal and H1N1 flu vaccines for the U.S. market AstraZeneca's MedImmune unit, CSL, GlaxoSmithKline Plc, Novartis AG and Sanofi-Aventis SA.. Fauci said he expects an upsurge of flu cases in the autumn, as weather cools and students return to school. (MSNBC -- Health)
Swine flu shots seem safe enough to test kids Aug 20, 2009
Five companies are making both seasonal and H1N1 flu vaccines for the U.S. market -- AstraZeneca's MedImmune unit, CSL, GlaxoSmithKline Plc, Novartis AG and Sanofi. HHS says 45 million doses of the H1N1 vaccine will be on hand in mid-October, when mass vaccination is planned. (MSNBC -- Health)
MedImmune to test swine flu vaccine Aug 19, 2009
MedImmune said it hopes to start getting some preliminary data within the month, and as early as two weeks. "If everything works well, we are expected to have our first doses ready by the end of October," said MedImmune spokeswoman Perla Copernik ... Already, the company has said that it expects to produce significantly more H1N1 vaccine doses than were ordered in two back-to-back Health and Human Services Department contracts totaling $151 million for MedImmune, one of five companies nationwide... (Baltimore Business Journal, MD)
H1N1 information Aug 18, 2009
The lecture will be by Dr. Tara Gonzales, a board certified pediatrician and of the Medical Science Directors for Medimmune, LLC.. Gonzales will speak about the H1N1 situation, the effects of the disease on high risk groups and what steps health professionals can take to reduce the risk of contracting virus. (Odessa American, TX)
U.S. Slashes Swine Flu Vaccine Estimate Aug 18, 2009
Clinical trials of the H1N1 vaccine are under way, and five companies are making it for the U.S. market -- AstraZeneca's MedImmune unit, CSL, GlaxoSmithKline Plc, Novartis AG and Sanofi-Aventis SA.. Dr. Robin Robinson of HHS said in a teleconference on Friday that Australia's CSL Biotherapiesmust produce swine flu vaccine first for Australia, where it is winter and both swine flu and seasonal flu are circulating, according to a news service run by the Center for Infectious Disease Research y at... (ABC News)
Schools Set For Extensive H1N1 Vaccinations Aug 17, 2009
Last year, FluMist maker MedImmune said it sent about 450,000 doses of the nasal spray vaccine to 140 school vaccination programs for regular seasonal flu. The company expects regular FluMist vaccinations to nearly double this year. (Click2Houston, TX)
Schools gear up for swine flu Aug 17, 2009
Last year, FluMist maker MedImmune said it sent about 450,000 doses of the nasal spray vaccine to 140 school vaccination programs ... ear, FluMist maker MedImmune said it sent about 450,000 doses of the nasal spray vaccine to 140 school vaccination programs. (Pocatello Idaho State Journal, ID)
Seasonal flu vaccine shipping early Aug 7, 2009
MedImmune, an AstraZeneca PLC subsidiary that sells a nasal spray seasonal flu vaccine, started shipments on July 28, about normal for the company. It plans to distribute about 10 million doses. (MSNBC -- Health)
Baxter to iron out distribution after finishing first flu vaccine batch Aug 6, 2009
AstraZeneca PLC, whose MedImmune unit makes smaller amounts of a flu vaccine that is sprayed into the nose rather than injected, said it would start clinical trials in the United States around Aug. 17. Baxter said it tested a "mock-up" vaccine made with a different pandemic strain in several clinical trials, clearing the way for European licensure. (Crain's Chicago Business)
Two swine flu vaccine trials launching Aug 5, 2009
AstraZeneca, whose MedImmune unit makes smaller amounts of a flu vaccine that is sprayed into the nose rather than injected, said it would start clinical trials in the United States around August 17 ... Initially, all the manufacturers except MedImmune which uses a different process struggled with low yields when making swine flu vaccine, with most companies only getting about 30 percent of the usual yield of seasonal flu strains. (MSNBC -- Health)
Caraco Pharmaceutical Laboratories, Ltd. Announces Settlement of Ethyol(R) ANDA Patent Litigation Aug 3, 2009
DETROIT, Aug. 3 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: ) announces today that it has executed a settlement agreement with MedImmune, stipulating the dismissal of the lawsuits filed in the United States District Court for the District of Maryland regarding the submission of an Abbreviated New Drug Application (ANDA) for a generic version of Ethyol(R). Under the settlement agreement, MedImmune grants Caraco a license to certain patents, permitting Caraco to... (PR Newswire)
Astra 2Q profit up 6 pct as it cuts costs Jul 31, 2009
AstraZeneca's MedImmune unit is working to deliver a nasal spray swine flu vaccine ... Brennan said that MedImmune may be able to produce a total of 200 million doses of bulk vaccine, of which 40 million doses can be filled and finished into nasal sprayers by March next year. (Yahoo News -- Pharmaceutical Industry News)
EphA2-targeted therapy delivers chemo directly to ovarian cancer cells Jul 30, 2009
Co-authors with Sood are Jeong-Won Lee, Hee Dong Han, Mian M. K. Shahzad, Seung Wook Kim, Lingegowda S. Mangala, Alpa M. Nick, Chunhua Lu, Rosemarie Schmandt, Hye-Sun Kim, Charles N. Landen, Robert L. Coleman, all of M. D. Anderson's Department of Gynecologic Oncology; Robert R. Langley, of M. D. Anderson's Department of Cancer Biology; Jeong-Won Lee, also of the Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Mian M. K.... (EurekAlert!)
